BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Agriculture AGR

Biomass Programs (Non-Funding) ---H.R.4373: Engineering Biology Research and Development Act of 2019 ---Implementation of the Agriculture Improvement Act of 2018 EPA Regulations on Biotechnology ---Efficient Science-Based Reviews of Biotech Products ---H.R.4373: Engineering Biology Research and Development Act ---Regulatory Treatment of Gene Edited Products FDA Regulations on Biotechnology ---H.R.4373: Engineering Biology Research and Development Act ---Regulatory Treatment of Gene Edited Products Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---International Consistency of Regulation for Gene Edited Products Funding for Biomass Crop Assistance Program ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for the USDA ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Genetically Engineered (GE) Animals ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Amendment to Restrict FDA Approval of GE Salmon ---Efficient Science-Based Review of Biotech Products ---H.R.4373:Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 ---FDA Proposed Guidance on Gene Editing ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---H.R.4373: Engineering Biology Research and Development Act ---FDA Proposed Guidance on Gene Editing ---International Consistency of Regulation for Gene Edited Products ---EPA Regulatory Approach to Gene Editing Review and Labeling of Food Derived from Biotechnology The United States-Mexico-Canada Agreement ---Ag-Biotech Provisions USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 ---Regulatory Treatment of Gene Edited Products ---USDA Part 340 Draft Rule

Contacted: Environmental Protection Agency (EPA); Office of the Vice President of the United States; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Justice, Dept of (DOJ); Treasury, Dept of; Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); White House Office

Bills named: S. 2522 (116th), H.R. 3164 (116th), H.R. 3055 (116th), H.R. 4373 (116th)

Budget/Appropriations BUD

Funding for Antimicrobial Resistance Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Biofuels ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960/S.2470: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3052/S.2580: Department of the Interior, Environment and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3163/S.2520: Transportation, and Housing and Urban Development, and Related Agencies Appropriations Act for FY 2020 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Rep. Craig Amendment #50 ------Rep. Perry Amendment #56 ---S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Biomass Crop Assistance Program ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Biorefineries ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for FDA ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3163/S.2520: Transportation, and Housing and Urban Development, and Related Agencies Appropriations Act for FY 2020 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Aderholt Full Committee Amendment on Germline Editing ---S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Health Resources and Services Administration (HRSA) ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) ---340B Program Integrity Issues ---Vaccine Injury Compensation Program (VICP) Funding for National Institutes of Health ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Renewable Chemicals/Bio-based Products ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960/S.2470: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for the National Vaccine Program Office (NVPO) ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for the USDA ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 -----Biotechnology and Agriculture Trade Program

Contacted: Justice, Dept of (DOJ); Agriculture, Dept of (USDA); SENATE; Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); White House Office; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Treasury, Dept of; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Natl Economic Council (NEC); Commerce, Dept of (DOC)

Bills named: H.R. 3052 (116th), H.R. 2740 (116th), S. 2522 (116th), S. 2470 (116th), H.R. 3055 (116th), H.R. 3164 (116th), H.R. 2960 (116th), S. 2520 (116th), S. 2580 (116th), H.R. 3163 (116th)

Trade (domestic/foreign) TRD

Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---International Consistency of Regulation for Gene Edited Products ---Japan Biotechnology Regulations ---Korea Biotechnology Regulations ---Like-minded Countries Initiatives Genetically Engineered (GE) Animals ---International Consistency of Regulation for Gene Edited Products Genetically Engineered (GE) Plants ---International Consistency of Regulation for Gene Edited Products Intellectual Property International Enforcement ---China The United States-Mexico-Canada Agreement ---IP Provisions ---Ag-Biotech Provisions

Contacted: Justice, Dept of (DOJ); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Treasury, Dept of; Office of the Vice President of the United States; Agriculture, Dept of (USDA); SENATE; U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Commerce, Dept of (DOC); White House Office

Bills named: S. 844 (116th), S. 2522 (116th), S. 377 (116th), H.R. 1046 (116th), H.R. 3164 (116th), S. 97 (116th), S. 771 (116th)

Medicare/Medicaid MMM

Biosimilars ---Patient Cost-Sharing ---Medicare Reimbursement Medicaid ---H.R.3 Lower Drug Costs Now Act of 2019 ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates ---Value-Based Arrangements Medicare Expansion ---S.1129: A bill to establish a Medicare-for-all national health insurance program of 2019 Reimbursement and Coverage of Innovative Products ---H.R.3 Lower Drug Costs Now Act of 2019 ---H.R.275: Medicare Prescription Drug Price Negotiation Act of 2019 ---H.R.488/S.99: Medicare Drug Price Negotiation Act of 2019 ---S.62: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---Administration Rebate Rule ---CMMI Authority ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Patient Cost-Sharing ---Protected Classes ---Step Therapy ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications

Contacted: Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); White House Office; Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); Agriculture, Dept of (USDA); SENATE; Food & Drug Administration (FDA); Treasury, Dept of; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO)

Bills named: S. 1129 (116th), S. 771 (116th), H.R. 275 (116th), H.R. 3 (116th), S. 62 (116th), H.R. 488 (116th), S. 99 (116th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960/S.2470: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.2051/S.999: Sustainable Chemistry Research and Development Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.4373: Engineering Biology Research and Development Act of 2019 ---Implementation of the Agriculture Improvement Act of 2018 ---Investment Tax Credit ---Production Tax Credit

Contacted: Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Justice, Dept of (DOJ); Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); Office of the Vice President of the United States; Office of Management & Budget (OMB); Patent & Trademark Office (PTO); White House Office; Treasury, Dept of; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH)

Bills named: S. 2522 (116th), H.R. 3164 (116th), H.R. 3055 (116th), H.R. 3249 (116th), H.R. 2051 (116th), H.R. 2960 (116th), H.R. 2740 (116th), S. 2470 (116th), S. 999 (116th), H.R. 4373 (116th), S. 1841 (116th)

Consumer Issues/Safety/Products CSP

Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 Genetically Engineered (GE) Animals ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---Efficient Science-Based Review of Biotech Products ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 ---FDA Proposed Guidance on Gene Editing ---International Consistency of Regulation for Gene Edited Products Opioid Crisis ---Coverage and Reimbursement ---FDA Reforms ---Implementation of the SUPPORT for Patients and Communities Act of 2018 ---NIH Research ---H.R.5590: Opioid Addiction Action Plan Act ---Transparency Review and Labeling of Food Derived from Biotechnology

Contacted: Natl Economic Council (NEC); SENATE; Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); White House Office; Justice, Dept of (DOJ); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Treasury, Dept of; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States

Bills named: H.R. 4373 (116th), H.R. 1046 (116th), H.R. 3164 (116th), H.R. 5590 (116th), S. 377 (116th), S. 97 (116th), S. 2522 (116th), S. 771 (116th), S. 844 (116th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.3301: The Taxpayer Certainty and Disaster Tax Relief Act of 2019 ---S.617: Tax Extender and Disaster Relief Act of 2019 ---Advanced and Second Generation Biofuels Tax Extenders Capital Formation Investment Incentives ---Reform of Net Operating Loss Rules ---Reintroduction of the American Innovation Act in the House ---Introduction of the American Innovation Act in the Senate Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---Investment Tax Credit ---Production Tax Credit Qualified Small Business Stock (QSBS) ---Section 1202 Research & Development Tax Credit Reforms ---Expensing of R&D Expenditures ---R&D Payroll Credit Vaccine Injury Compensation Tax ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019

Contacted: Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Economic Council (NEC); Office of the Vice President of the United States; Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Justice, Dept of (DOJ); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Treasury, Dept of; White House Office; Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC)

Bills named: H.R. 3249 (116th), S. 1841 (116th), H.R. 1973 (116th), S. 1654 (116th), H.R. 3301 (116th), S. 617 (116th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---Domestic Manufacturing Requirement ---March-In Rights Compulsory Licensing ---H.R.465/S.102: Prescription Drug Price Relief Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 Diversity in Patenting ---H.R.6390/S.3483: SUCCESS Act Drug Patenting ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous Prices (FLAT) Prices Act ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.440: Preserving Access to Cost Effective Drugs Act (PACED) Act of 2019 ---S.1416: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs Act of 2019 Intellectual Property International Enforcement ---China Inter Partes Review ---H.R.990/S.344 Hatch-Waxman Integrity Act of 2019 ---H.R.3666/S.2082: Support Technology and Research for Our Nation's Growth and Economic Resilience (STRONGER) Patents Act of 2019 ---S.440: Preserving Access to Cost Effective Drugs Act (PACED) Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---Implementation of the America Invents Act of 2011 Patent Reform ---H.R.3666/S.2082: Support Technology and Research for Our Nation's Growth and Economic Resilience (STRONGER) Patents Act of 2019 ---Patent Litigation Reforms Patenting of Biological Inventions ---Section 101 Modernization (Senate Discussion Draft- Sens. Coon/Tillis) The United States-Mexico-Canada Agreement ---IP Provisions

Contacted: Office of the Vice President of the United States; Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Treasury, Dept of; Natl Economic Council (NEC); U.S. Trade Representative (USTR); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 377 (116th), S. 440 (116th), S. 3483 (116th), S. 2082 (116th), H.R. 1188 (116th), S. 1416 (116th), H.R. 6390 (116th), H.R. 3199 (116th), S. 1895 (116th), H.R. 1499 (116th), S. 366 (116th), H.R. 3666 (116th), S. 344 (116th), S. 1617 (116th), H.R. 990 (116th), S. 102 (116th), H.R. 465 (116th), H.R. 1503 (116th), H.R. 1520 (116th), S. 64 (116th), H.R. 1046 (116th)

Health Issues HCR

340B Drug Discount Program ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---340B Optimization Act (Discussion Draft House/Senate) ---340B Pause Act (Discussion Draft House/Senate) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) ---Program Implementation & Oversight Access to Medicines/World Health Organization Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.269/S.1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 ---Gene Editing ---National Biodefense Strategy ---Pandemic Influenza Preparedness Biosimilars ---H.R.965/S.340: CREATES Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 ---Access to Samples for Testing ---Patient Cost-Sharing ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2017 ---Interchangeability and Pharmacy Substitution ---Medicare Reimbursement ---Naming ---Biosimilar Copay Elimination Comparative Effectiveness Research Initiatives ---Reauthorization of Patient-Centered Outcomes Research Institute Diagnostics and Personalized Medicine Regulation and Oversight ---VALID Act (Discussion Draft House) Drug Evaluation and Review ---FDA Review of CBD-Based Drugs ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 Drug Manufacturing, Quality & Distribution ---S.551 REFUND Act of 2019 ---Counterfeiting ---Drug Shortages ---Pharmacy Compounding & Oversight Drug Patenting ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous Prices (FLAT) Prices Act ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.1416: Affordable Prescriptions for Patients Act of 2019 ---H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs Act of 2019 Drug Pricing ---General ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.488/S.99: Medicare Drug Price Negotiation Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1093/S.378: Stop Price Gouging Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous Prices (FLAT) Prices Act of 2019 ---H.R.2069/S.474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 ---H.R.2376/S.1227: Prescription Pricing for the People Act of 2019 ---H.R.275: Medicare Prescription Drug Price Negotiation Act of 2019 ---H.R.2113: Prescription Drug STAR Act of 2019 ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---S.62: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 ---S.476: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---S.1416/H.R. 4398 : Affordable Prescriptions for Patients Act of 2019 ---H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) ---International Reference Pricing ---Administration International Pricing Index Proposal ---Direct Government Negotiation/Price Setting/Arbitration/Compulsory Licensing ---Medicare Part D Prescription Drug Program ---Medicare Part B Prescription Drug Program ---Value-based Contracting ---Rebate reform Funding for Antimicrobial Resistance Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for FDA ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3163/S.2520: Transportation, and Housing and Urban Development, and Related Agencies Appropriations Act for FY 2020 ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Aderholt Full Committee Amendment on Germline Editing Funding for Health Resources and Services Administration (HRSA) ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) ---340B Program Integrity Issues ---Vaccine Injury Compensation Program (VICP) Funding for National Institutes of Health ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for the National Vaccine Program Office (NVPO) ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Generic Drug Entry ---H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 ---H.R.965/S.340: CREATES Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---Access to Samples for Testing ---Incentives for Generic Drug Entry Medicaid ---H.R.3: Lower Drug Costs Now Act of 2019 ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates ---Value-Based Arrangements Medicare Expansion ---S.1129: A bill to establish a Medicare-for-all national health insurance program of 2019 Opioid Crisis ---Coverage and Reimbursement ---FDA Reforms ---Implementation of the SUPPORT for Patients and Communities Act of 2018 ---NIH Research ---H.R.5590: Opioid Addiction Action Plan Act ---Transparency Orphan Drug Issues ---Tax Credit Precision Medicine Initiative ---Genome Editing Reimbursement and Coverage of Innovative Products ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.275: Medicare Prescription Drug Price Negotiation Act of 2019 ---H.R.488/S.99: Medicare Drug Price Negotiation Act of 2019 ---S.62: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---Administration Rebate Rule ---CMMI Authority ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Patient Cost-Sharing ---Protected Classes ---Step Therapy ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications The United States-Mexico-Canada Agreement ---IP Provisions US-Japan Trade Agreement ---IP Provisions Vaccine Injury Compensation Tax ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019 Vaccines and Infectious Diseases ---H.R.2862/S.1619: Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019 ---S.1872: Protecting Seniors through Immunizations Act of 2019 ---Adult Immunization Education ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Office of the Vice President of the United States; White House Office; Securities & Exchange Commission (SEC); Treasury, Dept of; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Natl Economic Council (NEC); Commerce, Dept of (DOC)

Bills named: S. 378 (116th), H.R. 3991 (116th), S. 1895 (116th), H.R. 3199 (116th), H.R. 3 (116th), H.R. 5590 (116th), H.R. 4398 (116th), S. 474 (116th), S. 377 (116th), H.R. 1188 (116th), S. 1619 (116th), S. 476 (116th), S. 1227 (116th), S. 1379 (116th), H.R. 938 (116th), S. 62 (116th), S. 1416 (116th), H.R. 488 (116th), H.R. 269 (116th), H.R. 965 (116th), S. 1654 (116th), H.R. 2862 (116th), S. 366 (116th), S. 844 (116th), H.R. 2376 (116th), S. 2520 (116th), S. 340 (116th), S. 659 (116th), H.R. 1520 (116th), H.R. 1973 (116th), H.R. 2740 (116th), S. 2543 (116th), S. 99 (116th), H.R. 1503 (116th), H.R. 2113 (116th), H.R. 1499 (116th), S. 1129 (116th), S. 64 (116th), H.R. 3055 (116th), H.R. 2069 (116th), S. 2522 (116th), S. 1617 (116th), H.R. 3163 (116th), S. 771 (116th), H.R. 1046 (116th), H.R. 1093 (116th), H.R. 3164 (116th), S. 551 (116th), S. 97 (116th), S. 1872 (116th), H.R. 275 (116th)

Small Business SMB

Capital Market Enhancements ---Amended Definition of Smaller Reporting Company Proxy Advisory Services ---Reintroduction of the Corporate Governance Fairness Act in the Senate ---Corporate Governance Reform and Transparency ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---S.452: Fostering Innovation Act of 2019 ---Reintroduction of the Fostering Innovation Act in the House of Representatives ---Small Issuer Exemption Short Selling Transparency

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Justice, Dept of (DOJ); White House Office; U.S. Trade Representative (USTR); Natl Economic Council (NEC); Environmental Protection Agency (EPA); SENATE; Agriculture, Dept of (USDA); Office of the Vice President of the United States; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 452 (116th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---H.R.3006: Renewable Fuel Standard Integrity Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.3301: The Taxpayer Certainty and Disaster Tax Relief Act of 2019 ---S.617: Tax Extender and Disaster Relief Act of 2019 ---S.1288: Clean Energy for America Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Advanced and Second Generation Biofuels Tax Extenders ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 Biomass Programs (Non-Funding) ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 Biorefineries (Non-Funding) ---Implementation of the Agriculture Improvement Act of 2018 Funding for Biofuels ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960/S.2470: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3052/S.2580: Department of the Interior, Environment and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3163/S.2520: Transportation, and Housing and Urban Development, and Related Agencies Appropriations Act for FY 2020 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Rep. Craig Amendment #50 ------Rep. Perry Amendment #56 ---S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Biomass Crop Assistance Program ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Biorefineries ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Renewable Fuel Standard (RFS) ---H.R.3006: Renewable Fuel Standard Integrity Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Cellulosic Registration Applications for Corn Kernel Fiber ---E 15 EPA Implementation of RVP Waiver ---H.R.4373: Engineering Biology Research and Development Act ---RFS Reform ---Small Refinery Waivers

Contacted: Natl Economic Council (NEC); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Treasury, Dept of; Food & Drug Administration (FDA); Justice, Dept of (DOJ); U.S. Trade Representative (USTR); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); SENATE; Office of Management & Budget (OMB); Office of the Vice President of the United States; Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3164 (116th), S. 2520 (116th), S. 2470 (116th), H.R. 3055 (116th), H.R. 3163 (116th), H.R. 2740 (116th), S. 1840 (116th), S. 617 (116th), S. 2580 (116th), S. 2522 (116th), S. 1841 (116th), H.R. 3249 (116th), H.R. 3052 (116th), H.R. 2960 (116th), S. 1288 (116th), H.R. 3006 (116th), H.R. 3301 (116th), H.R. 4373 (116th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---H.R.3164/S. 2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 -----Amendment to Restrict FDA Approval of GE Salmon ---Efficient Science-Based Review of Biotech Products ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 ---FDA Proposed Guidance on Gene Editing ---International Consistency of Regulation for Gene Edited Products Review and Labeling of Food Derived from Biotechnology

Contacted: Agriculture, Dept of (USDA); Justice, Dept of (DOJ); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; Office of the Vice President of the United States; Treasury, Dept of; Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Bills named: S. 2522 (116th), H.R. 3164 (116th), H.R. 4373 (116th)

Animals ANI

Genetically Engineered (GE) Animals ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Amendment to Restrict FDA Approval of GE Salmon ---Efficient Science-Based Review of Biotech Products ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 ---FDA Proposed Guidance on Gene Editing ---International Consistency of Regulation for Gene Edited Products

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); White House Office; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Treasury, Dept of; Patent & Trademark Office (PTO); SENATE; Environmental Protection Agency (EPA); Justice, Dept of (DOJ); Agriculture, Dept of (USDA); Food & Drug Administration (FDA)

Bills named: H.R. 4373 (116th), H.R. 3164 (116th), S. 2522 (116th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---H.R.3006: Renewable Fuel Standard Integrity Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.3301: The Taxpayer Certainty and Disaster Tax Relief Act of 2019 ---S.617: Tax Extender and Disaster Relief Act of 2019 ---S.1288: Clean Energy for America Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Advanced and Second Generation Biofuels Tax Extenders ---H.R.4373: Engineering Biology Research and Development Act ---Implementation of the Agriculture Improvement Act of 2018 Biomass Programs (Non-Funding) ---H.R.4373: Engineering Biology Research and Development Act of 2019 ---Implementation of the Agriculture Improvement Act of 2018 Biorefineries (Non-Funding) ---Implementation of the Agriculture Improvement Act of 2018 Funding for Biofuels ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960/S.2470: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3052/S.2580: Department of the Interior, Environment and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3163/S.2520: Transportation, and Housing and Urban Development, and Related Agencies Appropriations Act for FY 2020 ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ------Rep. Craig Amendment #50 ------Rep. Perry Amendment #56 ---S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Biomass Crop Assistance Program ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Biorefineries ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---H.R.2960: Energy and Water Development and Related Agencies Appropriations Act for FY 2020 ---H.R.3055: Consolidated Appropriations Act of 2019 (which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development Appropriations Bills) ---H.R.3164: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Renewable Fuel Standard (RFS) ---H.R.3006: Renewable Fuel Standard Integrity Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Cellulosic Registration Applications for Corn Kernel Fiber ---E 15 EPA Implementation of RVP Waiver ---H.R.4373: Engineering Biology Research and Development Act ---RFS Reform ---Small Refinery Waivers

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Justice, Dept of (DOJ); SENATE; Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Treasury, Dept of; Natl Economic Council (NEC); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); White House Office; Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO)

Bills named: H.R. 3052 (116th), H.R. 3249 (116th), S. 617 (116th), S. 2520 (116th), S. 1288 (116th), H.R. 4373 (116th), H.R. 2740 (116th), H.R. 3006 (116th), H.R. 2960 (116th), H.R. 3164 (116th), H.R. 3163 (116th), S. 2470 (116th), S. 2580 (116th), H.R. 3301 (116th), S. 1840 (116th), H.R. 3055 (116th), S. 2522 (116th), S. 1841 (116th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.269/S.1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 ---Gene Editing ---National Biodefense Strategy ---Pandemic Influenza Preparedness Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate)

Contacted: Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Office of the Vice President of the United States; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); White House Office; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Justice, Dept of (DOJ)

Bills named: S. 1379 (116th), H.R. 2740 (116th), H.R. 269 (116th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.269/S.1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 ---Gene Editing ---National Biodefense Strategy ---Pandemic Influenza Preparedness Funding for Antimicrobial Resistance Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for National Institutes of Health ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate)

Contacted: Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); SENATE; Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Treasury, Dept of; Office of the Vice President of the United States; Natl Institutes of Health (NIH); White House Office; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Justice, Dept of (DOJ); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR)

Bills named: H.R. 2740 (116th), H.R. 269 (116th), S. 1379 (116th)